AbbVie pens another T cell engager deal, this time with Xilio
AbbVie and Xilio Therapeutics are partnering to make “masked” T cell engagers, which they hope will be safer than currently available options. Xilio said Wednesday the collaboration would develop new immunotherapies ...
AbbVie and Xilio Therapeutics are partnering to make “masked” T cell engagers, which they hope will be safer than currently available options.
Xilio said Wednesday the collaboration would develop new immunotherapies ...
